-
Dr. Guohong Han’s Team: Measuring Portal Pressure Gradient 24 Hours Post-TIPS Provides More Accurate Risk Prediction for Complications
Portal hypertension is a severe complication of chronic liver disease, directly associated with clinical outcomes such as ascites and variceal bleeding. Transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment that significantly reduces portal pressure. Portal pressure gradient (PPG) is commonly used to assess portal pressure in patients undergoing TIPS. Recently, a study conducted by…
-
WCLC Expert Commentary: Dr. Nan Bi Discusses the LAURA Study Results and the Challenges of EGFR-Positive LA-NSCLC Targeted Consolidation Therapy
The 2024 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer (IASLC), is currently underway in San Diego, USA. Oncology Frontier has invited leading Chinese lung cancer experts to analyze the key research data from this conference. This article highlights Dr. Nan Bi from the Cancer Hospital…
-
WCLC China Special Session: Exploring Global Lung Cancer Prevention and Evidence-Based Medicine
At the 2024 World Conference on Lung Cancer (WCLC), the International Association for the Study of Lung Cancer (IASLC), the Chinese Society of Clinical Oncology (CSCO), and the Chinese Alliance Against Lung Cancer (CAALC) came together once again to host a joint session. Held on Saturday, September 7, from 8:00 AM to 12:00 PM, the…
-
Dr.Yuankai Shi: INTELLECT Study Reveals mOS of 41.8 Months, Offering Prolonged Survival for NSCLC Patients Resistant to Crizotinib
The IASLC 2024 World Conference on Lung Cancer (WCLC 2024) was held in San Diego, CA USA on September 7th. The mOS data from the INTELLECT study was disclosed at the conference on September 8th. Oncology Frontier has invited the lead principal investigator of the INTELLECT study, Dr. Yuankai Shi from the Cancer Hospital Chinese Academy of Medical…
-
WCLC 2024 | Dr. Patel Discusses the Anticipation for IASLC’s 50th Anniversary Celebration
The 2024 World Conference on Lung Cancer (WCLC) marks the 50th anniversary of the International Association for the Study of Lung Cancer (IASLC). This milestone celebration will feature unique activities commemorating IASLC’s rich history, under the theme “Across the Decades.” The event will be held on September 8 in San Diego’s famous Gaslamp Quarter, where…
-
JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management
Despite the rising incidence of MASLD-related HCC, studies focusing on the clinical characteristics, survival, and prognosis of non-cirrhotic MASLD patients remain limited. The study aimed to uncover clinical features and…
-
PALACE Study: Long-Term Follow-Up Data After Removal of Penicillin Allergy Labels
The Penicillin Allergy Clinical Decision Rule (PALACE) study is the first international, multicenter randomized clinical trial to demonstrate that direct oral penicillin (DOC) in adult patients with low-risk penicillin allergy…
-
Early Detection of Minimal Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA
Recently, Professor Xiaofan Zhu, Director of the Division of Pediatric Hematology and Oncology Center at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Associate Chief Physician Doctor Min Ruan and Attending Doctor LiPeng Liu collaborated on a study titled “Early Detection of Minimal Residual Disease and Risk Stratification for Children…
Connecting Medical Expertise through Media